Literature DB >> 20197216

Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009.

Benedikt Fischer1, Nadine Nakamura, Brian Rush, Jürgen Rehm, Karen Urbanoski.   

Abstract

BACKGROUND: North America is the region with the world's highest prescription opioid (PO) use. Non-medical use of prescription opioids and PO-related morbidity and mortality have strongly increased in the US in recent years. It is assumed that similar trends are occurring in Canada, but there is less empirical evidence to support this. Treatment demand for problematic PO use is an important indicator of PO-related morbidity.
METHODS: Levels and changes related to the caseload of PO-related treatment admissions were assessed using system-level data from the Drug and Alcohol Treatment Information System (DATIS), the reporting system for publicly funded addiction treatment services in the province of Ontario (Canada) for the period April 2004-March 2009 (n=500,217). In addition, basic socio-demographic and clinical characteristics of PO-related treatment admissions in the final year of study (n=10,125) were examined.
RESULTS: The number of PO-related treatment admissions in DATIS rose by 60%, and their prevalence in the total caseload increased from 9.4% to 15.7% in the study period. Three-quarters of PO-clients reported other problem substances; the most common co-occurring problem substance was cocaine/crack. The majority of PO-clients were <35 years of age, unemployed, and referred to treatment by others.
INTERPRETATION: Demand for treatment for problematic PO use has risen substantially in Ontario in the past five years in the wider context of substantially increased overall PO use and related harms in Canada. The interaction dynamics between these different indicators need to be systematically examined and monitored as the basis for evidence-based interventions. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20197216     DOI: 10.1016/j.drugalcdep.2010.02.001

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  19 in total

1.  Opioids and chronic pain.

Authors:  Meldon M Kahan
Journal:  CMAJ       Date:  2012-01-10       Impact factor: 8.262

2.  Prescription opioid abuse: what is the real problem and how do we fix it?

Authors:  M E Lynch; Benedikt Fischer
Journal:  Can Fam Physician       Date:  2011-11       Impact factor: 3.275

3.  Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.

Authors:  Suzanne Nielsen; Maureen Hillhouse; Larissa Mooney; Alfonso Ang; Walter Ling
Journal:  J Subst Abuse Treat       Date:  2014-06-28

4.  Opiate withdrawal syndrome in buprenorphine abusers admitted to a rehabilitation center in Tunisia.

Authors:  Ines Derbel; Asma Ghorbel; Férièle Messadi Akrout; Abdelmajid Zahaf
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

5.  Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.

Authors:  Benedikt Fischer; Jürgen Rehm; Mark Tyndall
Journal:  CMAJ       Date:  2016-11-07       Impact factor: 8.262

6.  Heroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification.

Authors:  Shannon R Kenney; Genie L Bailey; Bradley J Anderson; Michael D Stein
Journal:  Addict Behav       Date:  2017-05-09       Impact factor: 3.913

7.  The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample.

Authors:  Suzanne Nielsen; Maureen Hillhouse; Roger D Weiss; Larissa Mooney; Jennifer Sharpe Potter; Joshua Lee; Marc N Gourevitch; Walter Ling
Journal:  Am J Addict       Date:  2013-09-24

8.  Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?

Authors:  Paul Kurdyak; Binu Jacob; Juveria Zaheer; Benedikt Fischer
Journal:  Can Fam Physician       Date:  2018-02       Impact factor: 3.275

9.  Laboratory-induced cue reactivity among individuals with prescription opioid dependence.

Authors:  Sudie E Back; Daniel F Gros; Jenna L McCauley; Julianne C Flanagan; Elizabeth Cox; Kelly S Barth; Kathleen T Brady
Journal:  Addict Behav       Date:  2014-04-12       Impact factor: 3.913

10.  Effect of a course-based intervention and effect of medical regulation on physicians' opioid prescribing.

Authors:  Meldon Kahan; Tara Gomes; David N Juurlink; Michael Manno; Lynn Wilson; Angela Mailis-Gagnon; Anita Srivastava; Rhoda Reardon; Irfan A Dhalla; Muhammad M Mamdani
Journal:  Can Fam Physician       Date:  2013-05       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.